| Association of maximal extent of resection of contrast-enhanced and non–contrast-enhanced tumor with survival within molecular subgroups of patients with newly diagnosed … AM Molinaro, S Hervey-Jumper, RA Morshed, J Young, SJ Han, ... JAMA oncology 6 (4), 495-503, 2020 | 396 | 2020 |
| Multifunctional nanoparticles for brain tumor imaging and therapy Y Cheng, RA Morshed, B Auffinger, AL Tobias, MS Lesniak Advanced drug delivery reviews 66, 42-57, 2014 | 344 | 2014 |
| Blood‐brain barrier permeable gold nanoparticles: an efficient delivery platform for enhanced malignant glioma therapy and imaging Y Cheng, Q Dai, RA Morshed, X Fan, ML Wegscheid, DA Wainwright, ... Small 10 (24), 5137-5150, 2014 | 271 | 2014 |
| Fibrin-binding, peptide amphiphile micelles for targeting glioblastoma EJ Chung, Y Cheng, R Morshed, K Nord, Y Han, ML Wegscheid, ... Biomaterials 35 (4), 1249-1256, 2014 | 158 | 2014 |
| Rotating magnetic field induced oscillation of magnetic particles for in vivo mechanical destruction of malignant glioma Y Cheng, ME Muroski, DCMC Petit, R Mansell, T Vemulkar, RA Morshed, ... Journal of Controlled Release 223, 75-84, 2016 | 150 | 2016 |
| Nuclear factor-κB in glioblastoma: insights into regulators and targeted therapy KE Cahill, RA Morshed, B Yamini Neuro-oncology 18 (3), 329-339, 2015 | 142 | 2015 |
| Cell-penetrating peptide-modified gold nanoparticles for the delivery of doxorubicin to brain metastatic breast cancer RA Morshed, ME Muroski, Q Dai, ML Wegscheid, B Auffinger, D Yu, ... Molecular pharmaceutics 13 (6), 1843-1854, 2016 | 141 | 2016 |
| Tuberculum sellae meningiomas: grading scale to assess surgical outcomes using the transcranial versus transsphenoidal approach ST Magill, RA Morshed, CHG Lucas, MK Aghi, PV Theodosopoulos, ... Neurosurgical focus 44 (4), E9, 2018 | 97 | 2018 |
| Nanoparticle‐programmed self‐destructive neural stem cells for glioblastoma targeting and therapy Y Cheng, R Morshed, SH Cheng, A Tobias, B Auffinger, DA Wainwright, ... Small 9 (24), 4123-4129, 2013 | 97 | 2013 |
| Drug-loaded nanoparticle systems and adult stem cells: a potential marriage for the treatment of malignant glioma? B Auffinger, R Morshed, A Tobias, Y Cheng, AU Ahmed, MS Lesniak Oncotarget 4 (3), 378, 2013 | 92 | 2013 |
| Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group P Karschnia, JS Young, A Dono, L Häni, T Sciortino, F Bruno, ST Juenger, ... Neuro-oncology 25 (5), 940-954, 2023 | 88 | 2023 |
| Dynamic in vivo SPECT imaging of neural stem cells functionalized with radiolabeled nanoparticles for tracking of glioblastoma SH Cheng, D Yu, HM Tsai, RA Morshed, D Kanojia, LW Lo, L Leoni, ... Journal of Nuclear Medicine 57 (2), 279-284, 2016 | 82 | 2016 |
| Awake glioma surgery: technical evolution and nuances AJ Gogos, JS Young, RA Morshed, SL Hervey-Jumper, MS Berger Journal of neuro-oncology 147, 515-524, 2020 | 75 | 2020 |
| Subcortical stimulation mapping of descending motor pathways for perirolandic gliomas: assessment of morbidity and functional outcome in 702 cases SJ Han, RA Morshed, I Troncon, KM Jordan, RG Henry, ... Journal of neurosurgery 131 (1), 201-208, 2018 | 62 | 2018 |
| βIII-Tubulin regulates breast cancer metastases to the brain D Kanojia, RA Morshed, L Zhang, JM Miska, J Qiao, JW Kim, P Pytel, ... Molecular cancer therapeutics 14 (5), 1152-1161, 2015 | 61 | 2015 |
| The management of low-grade gliomas in adults. RA Morshed, JS Young, SL Hervey-Jumper, MS Berger Journal of Neurosurgical Sciences 63 (4), 450-457, 2019 | 60 | 2019 |
| Triple motor mapping: transcranial, bipolar, and monopolar mapping for supratentorial glioma resection adjacent to motor pathways AJ Gogos, JS Young, RA Morshed, LN Avalos, RS Noss, ... Journal of neurosurgery 134 (6), 1728-1737, 2020 | 58 | 2020 |
| Analysis of glioblastoma tumor coverage by oncolytic virus-loaded neural stem cells using MRI-based tracking and histological reconstruction RA Morshed, M Gutova, J Juliano, ME Barish, A Hawkins-Daarud, ... Cancer gene therapy 22 (1), 55-61, 2015 | 58 | 2015 |
| Neural stem cells secreting anti-HER2 antibody improve survival in a preclinical model of HER2 overexpressing breast cancer brain metastases D Kanojia, IV Balyasnikova, RA Morshed, RT Frank, D Yu, L Zhang, ... Stem Cells 33 (10), 2985-2994, 2015 | 51 | 2015 |
| Interactive effects of molecular, therapeutic, and patient factors on outcome of diffuse low-grade glioma SL Hervey-Jumper, Y Zhang, JJ Phillips, RA Morshed, JS Young, ... Journal of Clinical Oncology 41 (11), 2029-2042, 2023 | 46 | 2023 |
Jacob S. YoungUniversity of California, San FranciscoEmail confirmado em ucsf.edu
